tiprankstipranks
Trending News
More News >
Anthera Pharmaceuticals (ANTH)
OTHER OTC:ANTH
US Market
Advertisement

Anthera Pharmaceuticals (ANTH) Price & Analysis

Compare
236 Followers

ANTH Stock Chart & Stats


ANTH FAQ

What was Anthera Pharmaceuticals’s price range in the past 12 months?
Currently, no data Available
What is Anthera Pharmaceuticals’s market cap?
Anthera Pharmaceuticals’s market cap is $2.62K.
    When is Anthera Pharmaceuticals’s upcoming earnings report date?
    The company’s upcoming earnings report date is not yet available.
    How were Anthera Pharmaceuticals’s earnings last quarter?
    Currently, no data Available
    Is Anthera Pharmaceuticals overvalued?
    According to Wall Street analysts Anthera Pharmaceuticals’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
      Does Anthera Pharmaceuticals pay dividends?
      Anthera Pharmaceuticals does not currently pay dividends.
      What is Anthera Pharmaceuticals’s EPS estimate?
      Anthera Pharmaceuticals’s EPS estimate for its next earnings report is not yet available.
      How many shares outstanding does Anthera Pharmaceuticals have?
      Anthera Pharmaceuticals has 26,179,000 shares outstanding.
        What happened to Anthera Pharmaceuticals’s price movement after its last earnings report?
        Currently, no data Available
        Which hedge fund is a major shareholder of Anthera Pharmaceuticals?
        Currently, no hedge funds are holding shares in ANTH

        Company Description

        Anthera Pharmaceuticals

        Anthera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of medicines for patients with unmet medical needs. It develops Sollpura, a non-porcine investigational pancreatic enzyme replacement therapy that is in Phase III clinical trial for the treatment of patients with exocrine pancreatic insufficiency; and Blisibimod, which is in Phase II clinical trial for the treatment of B-cell mediated autoimmune diseases, including immunoglobulin A nephropathy or IgA nephropathy. The company has license agreements with Amgen, Inc., and Eli Lilly and Company. Anthera Pharmaceuticals, Inc. was founded in 2004 and is based in Houston, Texas.

        Anthera Pharmaceuticals (ANTH) Earnings & Revenues

        Currently, no data available
        Please return soon. This page is being updated.
        Similar Stocks
        Company
        Price & Change
        Follow
        Biodexa Pharmaceuticals
        Nuwellis
        Salarius Pharmaceuticals
        Scinai Immunotherapeutics
        Oragenics

        Ownership Overview

        0.04%99.96%
        Insiders
        Mutual Funds
        0.04% Other Institutional Investors
        99.96% Public Companies and
        Individual Investors

        Options Prices

        Currently, No data available
        ---
        Popular Stocks
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis